Survey of delivery of parenteral antimicrobials in non-inpatient settings across Europe.


Journal

International journal of antimicrobial agents
ISSN: 1872-7913
Titre abrégé: Int J Antimicrob Agents
Pays: Netherlands
ID NLM: 9111860

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 23 06 2021
revised: 23 01 2022
accepted: 20 02 2022
pubmed: 2 3 2022
medline: 15 4 2022
entrez: 1 3 2022
Statut: ppublish

Résumé

Delivery of parenteral antimicrobials in non-inpatient settings (DPANS) may be through a dedicated outpatient parenteral antimicrobial therapy (OPAT) service, co-ordinated by hospital- or community-based specialised teams, or via an infusion service involving community-based health professionals (nurses, general practitioners) without centralised hospital oversight, or through ad hoc arrangements. DPANS varies among countries. Our objective was to describe how DPANS is organised at a national level in European countries. A survey (65-item self-administered questionnaire) was conducted from February-June 2019 among infection specialists in 34 European countries on behalf of the ESCMID Study Group for Antimicrobial Stewardship (ESGAP) and the British Society for Antimicrobial Chemotherapy (BSAC) OPAT initiative. Most countries (28/34; 82.4%) participated in the survey. DPANS was available in almost all (27/28; 96.4%) responding countries. DPANS was predominantly provided either via specialised OPAT services (17/28; 60.7%) or via infusion services (16/28; 57.1%), with 11 countries (39.3%) providing both services. A formal OPAT team structure with specifically trained staff was reported in only six countries (6/17; 35.3%). Some countries (4/28; 14.3%) had no structured services but practiced DPANS via ad hoc arrangements. The costs of all stages of the process were covered for patients managed by specialised OPAT/infusion services, either completely, partially or for specific patient groups in the majority (20/28; 71.4%) of countries. The main barriers to implement OPAT/infusion services were lack of organisational structure or guidelines. In conclusion, DPANS with respect to availability and organisation is highly heterogeneous in Europe. National/European guidelines may help improve and standardise DPANS.

Identifiants

pubmed: 35227827
pii: S0924-8579(22)00053-X
doi: 10.1016/j.ijantimicag.2022.106559
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Anti-Infective Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106559

Informations de copyright

Copyright © 2022 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.

Auteurs

Caroline Emilie (C)

Université de Lorraine, 34 Cours Léopold, 54000 Nancy, France; Département de Maladies Infectieuses et Tropicales, CHRU-Nancy, Rue du Morvan, 54500 Vandœuvre-lès-Nancy, France. Electronic address: caroline.emilie7@etu.univ-lorraine.fr.

Phebe de Nocker (P)

Department of Pharmacy, Ghent University Hospital, Corneel Heymanslaan 10, 9000 Ghent, Belgium.

Nadia Saïdani (N)

Centre Hospitalier de Cornouaille, Service de Maladies Infectieuses, 14 Avenue Yves Thépot, 29000 Quimper, France.

Mark Gilchrist (M)

Imperial College Healthcare NHS Trust, The Bays, South Wharf Road, London W2 1NY, UK.

R Andrew Seaton (RA)

Queen Elizabeth University Hospital, Infectious Diseases Unit, 1345 Govan Road, Glasgow G51 4TF, UK.

Sanjay Patel (S)

Department of Paediatric Infectious Diseases and Immunology, University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton SO16 6YD, UK.

Guillaume Beraud (G)

University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France.

Diamantis Kofteridis (D)

Department of Internal Medicine and Infectious Diseases, University Hospital of Heraklion, Panepistimiou, Iraklio 715 00, Crete, Greece.

Jeroen Schouten (J)

Department of Intensive Care Medicine, IQ Healthcare, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, the Netherlands.

Nathalie Thilly (N)

Université de Lorraine, CHRU-Nancy, Département Méthodologie, Promotion, Investigation, Rue du Morvan, 54500 Vandœuvre-lès-Nancy, France; APEMAC, Université de Lorraine, 34 Cours Léopold, 54000 Nancy, France.

Marvin Berrevoets (M)

Department of Internal Medicine, Elisabeth-Tweesteden Hospital, Doctor Deelenlaan 5, 5042 AD Tilburg, the Netherlands.

Marlies Hulscher (M)

Scientific Centre for Quality of Healthcare (IQ healthcare), Radboud University Medical Centre, Kapittelweg 54, 6525 EP Nijmegen, the Netherlands.

Franky Buyle (F)

Department of Pharmacy, Ghent University Hospital, Corneel Heymanslaan 10, 9000 Ghent, Belgium.

Céline Pulcini (C)

Université de Lorraine, 34 Cours Léopold, 54000 Nancy, France; Département de Maladies Infectieuses et Tropicales, CHRU-Nancy, Rue du Morvan, 54500 Vandœuvre-lès-Nancy, France; APEMAC, Université de Lorraine, 34 Cours Léopold, 54000 Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH